Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Lilly buys inflammation biotech Ventyx for $1.2B
Ventyx achieved its goal of securing Big Pharma commitment to its pipeline, with Lilly swooping in to buy the inflammation biotech for $1.2 billion.
James Waldron
Jan 8, 2026 7:01am
Philips claims AI cardiac imaging developer SpectraWAVE
Dec 15, 2025 10:35am
Sobi pays $950M upfront to snap up gout specialist Arthrosi
Dec 15, 2025 8:15am
Teleflex inks $2B in divestment deals for 3 company units
Dec 9, 2025 12:26pm
Mirum nets Bluejay and its ph. 3-stage hepatitis drug for $620M
Dec 8, 2025 9:45am
Stryker promotes president, COO to help lead its M&A strategy
Dec 8, 2025 9:40am
